Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Wallander

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Alimentary Pharmacology & Therapeutics|March 5, 2008
Relationship between symptom load of gastro-oesophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohortP Wahlqvist, M Karlsson, D Johnson, et al.
Alimentary Pharmacology & Therapeutics|August 19, 2007
Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a population-based studyC Jansson, H Nordenstedt, M-A Wallander, et al.
Alimentary Pharmacology & Therapeutics|September 24, 2004
Natural history of gastro-oesophageal reflux disease diagnosed in general practiceA Ruigómez, L A García Rodríguez, M-A Wallander, et al.
Alimentary Pharmacology & Therapeutics|October 9, 2007
Severe symptoms of gastro-oesophageal reflux disease are associated with cardiovascular disease and other gastrointestinal symptoms, but not diabetes: a population-based studyC Jansson, H Nordenstedt, M-A Wallander, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 19, 2008
Burden of gastroesophageal reflux disease in Shanghai, ChinaR Wang, X Yan, X-Q Ma, et al.
Alimentary Pharmacology & Therapeutics|September 5, 2007
Cost of gastro-oesophageal reflux disease to the employer: a perspective from the United StatesR A Brook, P Wahlqvist, N L Kleinman, et al.
American Journal of Epidemiology|September 3, 1999
Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomesA Ruigómez, L A García Rodríguez, C Cattaruzzi, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Ocular disorders in users of H2 antagonists and of omeprazoleS Mannino, M G Troncon, M A Wallander, et al.
Gut|April 22, 2008
Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro studyR M Zagari, L Fuccio, M-A Wallander, et al.
Minerva Cardioangiologica|December 8, 2010
Characteristics and drug utilization patterns of new users of rosuvastatin and other statins in four countriesA T McAfee, L A G Rodríguez, W G Goettsch, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Alimentary Pharmacology & Therapeutics|March 5, 2008
Relationship between symptom load of gastro-oesophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohortP Wahlqvist, M Karlsson, D Johnson, et al.
Alimentary Pharmacology & Therapeutics|August 19, 2007
Severe gastro-oesophageal reflux symptoms in relation to anxiety, depression and coping in a population-based studyC Jansson, H Nordenstedt, M-A Wallander, et al.
Alimentary Pharmacology & Therapeutics|September 24, 2004
Natural history of gastro-oesophageal reflux disease diagnosed in general practiceA Ruigómez, L A García Rodríguez, M-A Wallander, et al.
Alimentary Pharmacology & Therapeutics|October 9, 2007
Severe symptoms of gastro-oesophageal reflux disease are associated with cardiovascular disease and other gastrointestinal symptoms, but not diabetes: a population-based studyC Jansson, H Nordenstedt, M-A Wallander, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 19, 2008
Burden of gastroesophageal reflux disease in Shanghai, ChinaR Wang, X Yan, X-Q Ma, et al.
Alimentary Pharmacology & Therapeutics|September 5, 2007
Cost of gastro-oesophageal reflux disease to the employer: a perspective from the United StatesR A Brook, P Wahlqvist, N L Kleinman, et al.
American Journal of Epidemiology|September 3, 1999
Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomesA Ruigómez, L A García Rodríguez, C Cattaruzzi, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Ocular disorders in users of H2 antagonists and of omeprazoleS Mannino, M G Troncon, M A Wallander, et al.
Gut|April 22, 2008
Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro studyR M Zagari, L Fuccio, M-A Wallander, et al.
Minerva Cardioangiologica|December 8, 2010
Characteristics and drug utilization patterns of new users of rosuvastatin and other statins in four countriesA T McAfee, L A G Rodríguez, W G Goettsch, et al.
Pageof 6